Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biotica
Cambridge, England, United Kingdombiotica.com ↗
- Ownership
- Private
- Employees
- ~48
- Development stage
- Other
01
Overview
Biotica has developed polyketide therapeutics with clinical validation. Its rapamycin analogue program shows evidence of meaningful differentiation in diseases with significant unmet need, supported by extensive profiling by Pfizer in multiple sclerosis and systemic lupus erythematosus[2].
- Therapeutic areas
- PulmonologyImmunologyNeurologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Pfizer[2]GlaxoSmithKline[1][2]
Beyond the preview
Go deeper on Biotica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biotica.